NO910566L - Farmasoeytisk preparat. - Google Patents

Farmasoeytisk preparat.

Info

Publication number
NO910566L
NO910566L NO91910566A NO910566A NO910566L NO 910566 L NO910566 L NO 910566L NO 91910566 A NO91910566 A NO 91910566A NO 910566 A NO910566 A NO 910566A NO 910566 L NO910566 L NO 910566L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
acceptable salts
relates
physiologically acceptable
preparation containing
Prior art date
Application number
NO91910566A
Other languages
English (en)
Norwegian (no)
Other versions
NO910566D0 (no
Inventor
Rolf Gericke
Manfred Baumgarth
Ingeborg Lues
Rolf Bergmann
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO910566D0 publication Critical patent/NO910566D0/no
Publication of NO910566L publication Critical patent/NO910566L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO91910566A 1990-02-13 1991-02-12 Farmasoeytisk preparat. NO910566L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4004268A DE4004268A1 (de) 1990-02-13 1990-02-13 Pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
NO910566D0 NO910566D0 (no) 1991-02-12
NO910566L true NO910566L (no) 1991-08-14

Family

ID=6399970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910566A NO910566L (no) 1990-02-13 1991-02-12 Farmasoeytisk preparat.

Country Status (16)

Country Link
EP (1) EP0442141B1 (es)
JP (1) JPH04234813A (es)
KR (1) KR910015294A (es)
AT (1) ATE102031T1 (es)
AU (1) AU642961B2 (es)
CA (1) CA2036091A1 (es)
DE (2) DE4004268A1 (es)
DK (1) DK0442141T3 (es)
ES (1) ES2062287T3 (es)
HU (1) HU208483B (es)
IE (1) IE64207B1 (es)
IL (1) IL97211A (es)
NO (1) NO910566L (es)
NZ (1) NZ237092A (es)
PT (1) PT96719A (es)
ZA (1) ZA911074B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209071A1 (de) * 1992-03-20 1993-09-23 Merck Patent Gmbh Pharmazeutische zubereitung
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
DE59004798D1 (de) 1994-04-07
IE910473A1 (en) 1991-08-14
JPH04234813A (ja) 1992-08-24
ZA911074B (en) 1991-11-27
HU910463D0 (en) 1991-08-28
CA2036091A1 (en) 1991-08-14
EP0442141A1 (de) 1991-08-21
PT96719A (pt) 1991-10-31
IE64207B1 (en) 1995-07-12
NZ237092A (en) 1993-01-27
EP0442141B1 (de) 1994-03-02
IL97211A0 (en) 1992-08-18
DE4004268A1 (de) 1991-08-14
ES2062287T3 (es) 1994-12-16
ATE102031T1 (de) 1994-03-15
DK0442141T3 (da) 1994-03-28
HUT59593A (en) 1992-06-29
NO910566D0 (no) 1991-02-12
KR910015294A (ko) 1991-09-30
IL97211A (en) 1995-07-31
AU642961B2 (en) 1993-11-04
HU208483B (en) 1993-11-29
AU7102991A (en) 1991-08-15

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
SE8700498D0 (sv) Novel pharmaceologically active compounds
FI940072A0 (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
SE8404065D0 (sv) Novel biologically active compounds
DE68921908D1 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
DE69017969D1 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
NO910566L (no) Farmasoeytisk preparat.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
DE3879985D1 (de) Anticonvulsive agenzien.
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DE68907609D1 (de) Arzneimittelzusammensetzung.
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
ATE79539T1 (de) Pharmazeutische zusammensetzung enthaltend 1isopropyldihydrolysergsaeure.
IT9048526A0 (it) Composizione adesiva stabilizzante anidra per protesi dentarie.
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.
DE3686177D1 (de) Gut absorbierende pharmazeutische zusammensetzungen.
DK77591D0 (da) Blood deliming
ITMI912766A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
MX9203372A (es) Composiciones farmaceuticas de buspirona y sales de la misma, de aplicacion oral.
ATE82138T1 (de) Geregelte verabreichungszusammensetzung.
DK0779075T3 (da) Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler
IT8322815A0 (it) Formulazioni farmaceutiche adattivita' antisettica.